If I'm understanding this right, they used a machine learning algorithm to identify some markers in the blood of Parkinson's patients, and now they're testing for those markers. The AI in question is ML, and isn't involved in the actual testing.

Meanwhile, we’re finding out that many of the hotshot AI breakthroughs were oversold. Hopefully this is not going to be another disaster.